PRESS RELEASES

Vantage Health and Scripps Translational Science Institute form Strategic Partnership for Mobile Health Technology

February 10, 2014

Vantage Health Inc, (OTCQB: VNTH) and its parent company Nanobeak Inc. today announced that they have formed a strategic partnership with Scripps Translational Science Institute (STSI) for the advancement of mobile health technology.
 
Vantage Health is developing personalized and point-of-care screening using Apps based upon chemical sensing residing within a small device attached to a smartphone.
 

Vantage Health Receives License After NASA and Nanobeak Enter into an Exclusive Five-Year Commercial License Agreement

January 7, 2014

Vantage Health Inc, (OTCB: VNTH) and its parent company Nanobeak Inc. today announced that NASA and Nanobeak have entered into an exclusive 5-year license agreement to commercialize mobile healthcare products derived from NASA patented chemical sensing technology. This exclusive 5-year license agreement has been sublicensed to Vantage Health Inc.
 

Pages